Korea and WHO jointly announce 'Medical AI for All'
- Input
- 2026-10-21 09:30:00
- Updated
- 2026-10-21 09:30:00

The Ministry of Health and Welfare announced on the 21st that, together with the WHO, it would host the 2026 World Bio Summit through the 22nd at the COEX Magok Convention Center in Seoul, under the theme 'Spreading Biohealth Innovation Driven by AI.' The event, organized by the Korea Health Industry Development Institute, will bring together health authorities from various countries, international organizations, pharmaceutical, biotech and AI companies, and academia to discuss the development of medical AI and ways to strengthen global healthcare cooperation.
Tedros Adhanom Ghebreyesus's visit to Korea as WHO director-general comes 11 years after former WHO Director-General Margaret Chan visited the country in 2015 to attend the World Congress of Nurses.
At the opening ceremony that day, Minister Jeong and Director-General Tedros jointly announced the 'AI Healthcare Seoul Declaration for Responsible Innovation and Global Solidarity.' The declaration emphasized that the benefits of AI innovation should be shared equitably by all humanity, rather than concentrated in particular countries or social groups. To that end, it called for the safe and responsible use of medical AI, as well as international solidarity and cooperation to reduce healthcare disparities between countries.
Minister Jeong said, "The AI Healthcare Seoul Declaration, jointly announced with the WHO, is a historic commitment to put human life and dignity first, realize 'AI Basic Healthcare,' and stand in solidarity with the international community." She added, "The Ministry of Health and Welfare will continue to lead responsible AI innovation and take the initiative to ensure that everyone can share in the benefits of AI development."
Minister Jeong is scheduled to hold bilateral meetings with the health ministers of Türkiye, Armenia, Tunisia and Qatar to discuss cooperation on health insurance, medical AI, the overseas expansion of Korean pharmaceuticals, patient referrals and medical personnel training, and digital health.